Withings

Withings is a French maker of connected health devices: hybrid analog smartwatches (ScanWatch line), smart scales, blood pressure monitors, a sleep analyzer and the BeamO 4-in-1 checkup device. It makes most of its money from hardware; in 2025, 66% of revenue came from FDA-cleared medical devices. It also sells an optional Withings+ subscription ($9.95 a month or $99.95 a year) and runs a B2B remote-patient-monitoring division, Withings Health Solutions (17% of revenue).

7 devices · 8 clearances on file · researched 2026-11-08

Headquarters
Issy-les-Moulineaux, France
Founded
2008
Ownership
Private
Focus
heart health, sleep, fitness, women's health, medical
Membership
Withings+ · $9.95/mo · $99.95/yr · optional ↗Includes Cardio Check-Up (board-certified cardiologist review of ECGs within 24h; Heartbeat Health in the US): 4 per year on the annual plan, 1 per 90 days on the monthly plan. It is also needed for the Vitality Indicator (HealthSense 4). Accounts created on or after 13 Oct 2026 need Withings+ for automatic sync to Apple Health and other third-party apps. Gizmodo (Sept 2025) gave $99.50 a year; the company's CES 2025 release says $99.95.
Users
15,000,000 active users (3.6 million of them classified as medical users) (2025) ↗
Leadership
Éric Carreel Co-founder, Chairman and President ↗
Cédric Hutchings Co-founder (former CEO; led Nokia's Digital Health business after the 2016 acquisition) ↗
Employees
400 (2026, 'a global team of 400' (company release, April 2026)) ↗
Last round
Series B · 2020-07 · $60M
Investors
Gilde Healthcare, Idinvest Partners, Bpifrance, BNP Paribas Developpement, Oddo BHF Private Equity, Adelie Capital, Ventech, 360 Capital Partners
1

Devices

Each device as the maker lists it; a dash means no source states the figure.

DeviceFormStatusSensorsBatteryPrice
ScanWatch Nova Brilliant ↗2025-01Named as 'the new ScanWatch Nova Brilliant' among the ECG devices that support Cardio Check-Up in the CES 2025 press release. watchOn sale ECG — —
BPM Vision ↗2025-01Upper-arm cuff monitor with a large color screen, Wi-Fi sync, a six-month battery and up to 8 users. otherOn sale blood pressure (cuff) — $129.95US$129.95 announced at CES on 7 Jan 2025; planned for US-only sale from April 2025 after FDA clearance
ScanWatch Nova ↗2023-12Luxury stainless-steel version of the ScanWatch 2 with sapphire glass and 10 ATM water resistance. It reports breathing disturbances during sleep. watchOn sale optical HR, SpO2, skin temperature, ECG, accelerometer 30 d $599.95US$599.95 at launch, 5 Dec 2023
ScanWatch 2 ↗2023-08Hybrid analog watch with a small grayscale OLED; 24/7 body-temperature variation, HRV, cycle tracking and 40+ auto-detected activities. HealthSense 4 (IFA 2025) added REM sleep tracking and the Vitality Indicator, which needs Withings+. watchOn sale optical HR (MultiWave PPG, 4 wavelengths, 16 channels), SpO2, skin temperature, ECG, accelerometer 30 d $369.95EUR 349.95 at pre-order (31 Aug 2023); US$369.95 for the blue/silver 42mm version, Sept 2025 (Gizmodo), with one month of Withings+ included
ScanWatch Light ↗2023-08Cheapest ScanWatch, covering heart health, activity, cycle and sleep tracking. It has no temperature sensor and does not get HealthSense 4 (Gizmodo, 2025-09). The source names no individual sensors. watchOn sale — 30 d EUR 249.95 at pre-order (31 Aug 2023), 37mm
BeamO ↗'4-in-1 MultiScan checkup device'. Its ECG got FDA 510(k) K252474 on 2025-11-10 (as 'Withings BeamO (SCT02)'). otherOn sale ECG — —
BPM Core ↗2019Introduced in 2019; adds ECG and a digital stethoscope that listens for some heart valve defects. Current sale status was not confirmed. other— blood pressure (cuff), ECG, digital stethoscope — —
2

Regulatory clearances

Health features a regulator has cleared, with the decision number.

FeatureDeviceAgencyTypeNumberDate
ECG (OTC electrocardiograph software) ↗Withings ECG AppFDA510(k)K2407952025-06
ECG (electrocardiograph) ↗Withings BeamO (SCT02)FDA510(k)K2524742025-11
sleep apnea (ventilatory effort recorder, product code MNR) ↗Withings Sleep RxFDA510(k)K2316672024-09
ECG (electrocardiograph) ↗Withings Scan Monitor 2.0FDA510(k)K2308122023-08
ECG (electrocardiograph); company says ScanWatch is cleared for AFib detection by ECG and for SpO2 ↗Scan Monitor (ScanWatch)FDA510(k)K2014562021-10
temporal thermometer ↗Withings Thermo (Model SCT01)FDA510(k)K1605442016-06
blood pressure (cuff) ↗Withings Blood Pressure MonitorFDA510(k)K1331252014-03
blood pressure (cuff) ↗Withings Blood Pressure MonitorFDA510(k)K1108722011-05
3

Partnerships

Teams, leagues, insurers and health systems that use or resell the devices.

  • 2025-01Heartbeat Health — Provides Cardio Check-Up cardiologist ECG review in the US inside Withings+ (DPV Analytics in France and Germany) ↗
  • 2026-04MedStar Health, Calibrate, 9amHealth — Named as health systems and programs that deploy Withings devices with their patients (Withings Health Solutions, more than 740K enrolled patients; 500,000+ in obesity-care programs) ↗
  • 2026-04Best Buy, Target, Apple, Dick's Sporting Goods, Optum, FSAstore.com — US retail distribution ↗
  • 2023-04American Diabetes Association — Since 2023, ADA members get free access to smart-scale data and live coaching ↗
4

Dated facts

Launches, lawsuits, acquisitions and filings, newest first.

  • 2026-10From 13 Oct 2026, automatic sync to Apple Health and other third-party apps is part of Withings+ (US$100 a year) for new accounts; existing accounts keep free sync. Users criticised the change. ↗
  • 2026-04Withings announced full-year profitability for 2025. The US is its largest market, and it reinvested 20-27% of revenue in R&D each year from 2018 to 2025. ↗
  • 2025-11FDA cleared BeamO's ECG (K252474) on 10 Nov 2025. ↗
  • 2025-09HealthSense 4 software and a blue/silver 42mm ScanWatch 2 ($369.95) were announced at IFA 2025. ↗
  • 2025-06FDA 510(k) clearance K240795 for the Withings ECG App (OTC ECG software, product code QDA). ↗
  • 2025-01BPM Vision and the Cardio Check-Up service were unveiled at CES 2025. ↗
  • 2022Withings acquired Impeto Medical and the fitness and meal-planning app 8fit. ↗
  • 2020-07Raised a $60M Series B co-led by Gilde Healthcare, Idinvest Partners and Bpifrance. ↗
  • 2018-05Co-founder Éric Carreel bought the company back from Nokia, two years after Nokia acquired it for EUR 164 million / $194 million (deal closed 31 May 2016). ↗
  • 2014Withings announced the first hybrid watch (Activité). ↗
5

Not yet confirmed

Claims seen in only one non-official place. Shown so they can be checked, not as findings.

  • Mathieu Letombe as current CEO: MarketScreener and actuia.com (July 2026) list him as CEO; Journal du Net says he became managing director in July 2018; Crunchbase calls him a former CEO. Not confirmed on a 2026 company page.
  • ScanWatch 2 battery 'up to 35 days', 5 ATM, sapphire glass and altimeter: from the withings.com product page as quoted in a search summary (withings.com is blocked). The Gizmodo headline also says 35 days.
  • BPM Vision US selling price of $179.95 and ECG added in autumn 2025: thewearify.com, the-gadgeteer.com and Notebookcheck (search summaries only, not opened). No FDA 510(k) under applicant Withings was found for BPM Vision or BPM Core.
  • ScanWatch Nova Brilliant priced at $599.95 / GBP 549.95 / EUR 599.95: search summary of Notebookcheck.
  • Scan Monitor 2.0 (K230812) is the Body Scan scale: inferred from Wikipedia/Engadget (25 Aug 2023, 'FDA approval for Body Scan'); the openFDA record does not name Body Scan.
  • Cumulative funding of about $93.8M over three rounds: aggregators (ZoomInfo/Crunchbase-type) only. The company release says 'EUR 61M / $71.42M in funding since 2019'.
  • Earlier rounds: $3.8M from Ventech (Sept 2010) and $30M from Bpifrance, Idinvest, 360 Capital and Ventech (July 2013), per Wikipedia citing TechCrunch (not fetched).
  • Employees 420 (2025) / 429 (2024): Revelio Labs estimate, search summary only.
S

Sources

Retrieved 2026-11-08.